A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete freund’s adjuvant in patients with resected high-risk melanoma

Jeffrey S. Weber, Flora L. Hua, Lucy Spears, Verna Marty, Catherine Kuniyoshi, Esteban Celis

Research output: Contribution to journal › Article › peer-review

120 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete freund’s adjuvant in patients with resected high-risk melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences